Quantum BioPharma Ltd Sustainability Reports
Quantum BioPharma Ltd. is a biopharmaceutical company specializing in the research and development of treatments for neurodegenerative disorders, metabolic disorders, and alcohol misuse disorders. Its lead pipeline candidate is Lucid-MS, a patented clinical-stage compound being developed for the treatment of multiple sclerosis.
Sector: Manufacturing
Country: Canada
Exchange: Canadian Securities Exchange
LEI: 529900Z3CEEEN7U9B668
7 reports from 2019 to 2025